MondegarAI
Knoll Capital Management, LLC

Q2 2025 · 13F-HR

Knoll Capital Management, LLCholdings as filed

Filed 2025-08-14 · accession 0001104659-25-078541

$140.7M
Reported value
38
Positions
2025-06-30
Period end
View analyzed profile →PRO

The Brief · Knoll Capital Management, LLC · Q2 2025

AI · grounded in 13F

Knoll Capital Management, LLC established a new position in Aldeyra Therapeutics Inc ALDX worth $20.97M. The fund also initiated stakes in Biohaven Pharmactl Hldg Co L for $12.63M and Entera Bio Ltd ENTX for $11.18M. Additional new positions include the SPDR Gold Trust GLD at $9.75M and MeiraGTX Holdings MGTX at $8.15M.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
01438T106ALDXAldeyra Therapeutics Inc$21.0M14.9%5,475,516CommonSOLE
G11196105Biohaven Pharmactl Hldg Co L$12.6M8.98%895,269CommonSOLE
M40527109ENTXEntera Bio Ltd$11.2M7.95%5,881,879CommonSOLE
78463V107GLDSPDR Gold Trust$9.8M6.94%32,000CommonSOLE
G59665102MGTXMeiraGTX Holdings$8.2M5.79%1,250,000CommonSOLE
496902404KGCKinross Gold Corp$6.9M4.89%440,000CommonSOLE
008474108AEMAgnico Eagle Mines Ltd$6.6M4.69%55,500CommonSOLE
80013R206AYS1Sandstorm Gold Ltd$6.6M4.68%700,000CommonSOLE
05337M104Avadel Pharmaceuticals Plc$5.3M3.78%600,000CommonSOLE
28657F103ELTXElicio Therapeutics Inc$4.9M3.46%630,915CommonSOLE
83056P715SKESKEENA RES LTD CAD$4.7M3.34%295,400CommonSOLE
811916105SASEABRIDGE GOLD INC$4.6M3.27%317,003CommonSOLE
02155H200ALTAltimmune Inc$4.3M3.09%1,121,524CommonSOLE
351858105FNVFranco Nev Corp$4.1M2.91%25,000CommonSOLE
55903Q104MQ8Mag Silver Corp$3.6M2.55%170,000CommonSOLE
67080N101NUVBNuvation Bio Inc$2.9M2.08%1,025,000CommonSOLE
46428Q109SLViShares Silver Trust$2.6M1.87%80,000CommonSOLE
03828A101APLTApplied Therapeutics Inc$2.4M1.72%7,799,687CommonSOLE
67576A100OCULOcular Therapeutix Inc.$1.9M1.32%600,400CommonSOLE
718172109PMPhilip Morris Intl. Inc$1.8M1.29%10,000CommonSOLE
92826C839VVisa$1.7M1.22%4,850CommonSOLE
780287108RGLDRoyal Gold Inc.$1.6M1.14%9,000CommonSOLE
464288760ITAiSHares US Aerospace & Defense$1.4M1.03%7,650CommonSOLE
099502106BAHBooz Allen Hamilton HLDG COR$1.4M0.96%13,000CommonSOLE
011532108AGIAlamos Gold Inc$1.3M0.94%50,000CommonSOLE
962879102WPMWheaton Precious Metals Corp$1.1M0.80%12,500CommonSOLE
666807102NOCNorthrop Grumman Corp$1.1M0.77%2,165CommonSOLE
192108504CDECoeur Mining Inc$851,7290.61%96,132CommonSOLE
589492107MREOMereo Biopharma Group$705,8730.50%260,470CommonSOLE
25243Q205DEODiageo PLC$680,6700.48%6,750CommonSOLE
925050106VRNAVerona Pharma$666,6940.47%7,049CommonSOLE
64782A107NEWPNew Pac Metals Corp$649,9000.46%485,000CommonSOLE
43906K100HOOKGBPHOOKIPA PHARMA$625,7740.44%498,625CommonSOLE
00289Y206ABEOAbeona Therapeutics$356,0730.25%62,689CommonSOLE
152006102CGAUCenterra Gold Inc$170,3000.12%1,227,863CommonSOLE
68572M106OBIOOrchestra BioMed Holdings$169,8240.12%455,128CommonSOLE
14161Y200CRDLCardiol Therapeutics Inc$136,0000.10%100,000CommonSOLE
68619K105Orgenesis, Inc.$74,6680.05%50,623CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.